Men's Health News

RSS

New genomic fingerprint may predict prostate cancer risk in African American men

African American men are more likely to develop prostate cancer than European American men, and are also more than twice as likely to die from it. Although there are many reasons that contribute to this health disparity, new research shows that African American men may have a distinctly different type of prostate cancer than European American men, according to new genomic fingerprinting results.

21 Jul 2015

UCLA scientists identify new method to deliver glucose to pancreatic and prostate cancer cells

UCLA scientists have for the first time identified a new sodium-dependent mechanism to deliver glucose—the body's main fuel that drives tumor growth—to pancreatic and prostate cancer cells, offering new hope in the fight against two of the deadliest forms of the disease.

21 Jul 2015

New UTMB study finds no association between testosterone therapy and blood clots in veins

A new study from The University of Texas Medical Branch at Galveston of more than 30,000 commercially insured men is the first large comparative analysis to show that there is no link between testosterone therapy and blood clots in veins. The study found that middle-aged and older men who receive testosterone therapy are not at increased risk of this illness.

21 Jul 2015

NeoGenomics announces launch of new germline cancer predisposition testing services

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today the launch of a new line of germline cancer predisposition testing services. The new tests include comprehensive testing for BRCA1 and BRCA2 encompassing an analysis of all exons and adjacent intronic regions.

20 Jul 2015

Self-quantification extends to the detection of depression

A small study conducted by Northwestern University Feinberg School of Medicine has shown that the time spent using a smart phone in conjunction with GPS location sensor data can be used to signal the development of depression.

19 Jul 2015

MES announces worldwide release of new automated sperm quality analyzer

Medical Electronic Systems today announced the worldwide release of the SQA-Vision, the company's new automated sperm quality analyzer. The SQA-Vision was developed based on 10 years of market feedback and is positioned to augment the company's line of SQA-V and QwikCheck semen analyzers with a top of the line solution.

17 Jul 2015

Increased radiation dose offers survival benefit for men with medium- and high-risk prostate cancer

Increased radiation dose is associated with higher survival rates in men with medium- and high-risk prostate cancer, but not men with low-risk prostate cancer, according to a new study from Penn Medicine published this week in JAMA Oncology. Already-high survival rates for men with low-risk prostate cancer were unaffected by higher radiation dosages compared to lower radiation dosages.

17 Jul 2015

New study evaluates impact of U.S. Preventive Services Task Force Guidelines for PSA screening

Current U.S. Preventive Services Task Force Guidelines for prostate screening may be impacting the detection of high-risk prostate cancer.

14 Jul 2015

Single molecule appears to be central regulator driving cancer metastasis

Cancer is a disease of cell growth, but most tumors only become lethal once they metastasize or spread from their first location to sites throughout the body. For the first time, researchers at Thomas Jefferson University in Philadelphia report a single molecule that appears to be the central regulator driving metastasis in prostate cancer.

14 Jul 2015

Lumen 100-LED system integrated by Microptic allows fast, accurate sperm viability testing

Prior Scientific reports that its Lumen 100-LED has been integrated by Microptic SL to provide illumination for their Sperm Class Analyser system.

From Prior Scientific Instruments Ltd. 14 Jul 2015

Researchers develop sperm RNA diagnostic test to help determine best infertility treatment for couples

A Wayne State University School of Medicine professor, in collaboration with researchers at CReAte Fertility Center, University of Toronto, Harvard University and Georgia Reagents University, has developed the first diagnostic test for sperm RNA based on next-generation sequencing. For couples with unexplained infertility, the test may help determine the best infertility treatment for couples having difficulty conceiving.

12 Jul 2015

Study examines recent trends in community-based practices to improve management of localized prostate cancer

After years of overtreatment for patients with low-risk prostate cancer, rates of active surveillance/ watchful waiting increased sharply in 2010 through 2013, and high-risk disease was more often treated appropriately with potentially curative local treatment rather than androgen deprivation alone, according to a study in the July 7 issue of JAMA.

8 Jul 2015

IRB Barcelona scientists provide molecular details about Seckel Syndrome

Today in Nature Communications, scientists at the Institute for Research in Biomedicine (IRB Barcelona) provide molecular details about Seckel Syndrome, a rare disease that causes microcephaly, or small brain, and growth delays.

8 Jul 2015

Spotting the symptoms of advanced prostate cancer: an interview with Brian Tomlinson

The main symptoms of advanced prostate cancer can include (but are not limited to) difficulty walking or climbing steps, unexplained pain, troubled sleep and taking pain relievers daily.

From CancerCare 7 Jul 2015

Sociologists to explore ideas, scientific research relating to sexuality at ASA's Annual Meeting

More than 5,500 sociologists will convene in Chicago this August to explore ideas and scientific research relating to sexuality and many other topics, as part of the American Sociological Association's 110th Annual Meeting. This year's theme, "Sexualities in the Social World," shows the importance of research by sociologists in illuminating how social norms and social inequalities affect what sexual behavior is acceptable and who partners with whom.

7 Jul 2015

Expectant management remains underused for men with low-risk prostate cancer

Monitoring men with very low- and low-risk prostate cancers using watchful waiting or active surveillance, called expectant management, is a useful approach for a large number of men with localized tumors and could spare them the debilitating side effects of aggressive treatments that are too often unnecessarily used in this patient population, a UCLA review of common practices in prostate cancer has found.

7 Jul 2015

Testosterone, cortisol hormones may destabilise financial markets by making traders take more risks

The hormones testosterone and cortisol may destabilise financial markets by making traders take more risks, according to a study. Researchers simulated the trading floor in the lab by having volunteers buy and sell assets among themselves. They measured the volunteers' natural hormone levels in one experiment and artificially raised them in another.

3 Jul 2015

Men referred for borderline testosterone levels have much higher rates of depression than general population

Researchers at the George Washington University, led by Michael S. Irwig, M.D., found that men referred for tertiary care for borderline testosterone levels had much higher rates of depression and depressive symptoms than those of the general population.

2 Jul 2015

New research links mutations in TEX11 gene to some cases of male infertility

In the most severe form of male infertility, men do not make any measurable levels of sperm. This condition, called azoospermia, affects approximately 1 percent of the male population and is responsible for about a sixth of cases of male infertility.

2 Jul 2015

Loyola offers holistic approach to help couples manage their sexual health

Cancer and cancer therapies are frequently associated with sexual dysfunction, yet this condition often goes untreated, according to specialists at Loyola Medicine's Sexual Wellness Clinic.

1 Jul 2015

Men's Health News

New genomic fingerprint may predict prostate cancer risk in African American men

UCLA scientists identify new method to deliver glucose to pancreatic and prostate cancer cells

New UTMB study finds no association between testosterone therapy and blood clots in veins

NeoGenomics announces launch of new germline cancer predisposition testing services

Self-quantification extends to the detection of depression

MES announces worldwide release of new automated sperm quality analyzer

Increased radiation dose offers survival benefit for men with medium- and high-risk prostate cancer

New study evaluates impact of U.S. Preventive Services Task Force Guidelines for PSA screening

Single molecule appears to be central regulator driving cancer metastasis

Lumen 100-LED system integrated by Microptic allows fast, accurate sperm viability testing

Researchers develop sperm RNA diagnostic test to help determine best infertility treatment for couples

Study examines recent trends in community-based practices to improve management of localized prostate cancer

IRB Barcelona scientists provide molecular details about Seckel Syndrome

Spotting the symptoms of advanced prostate cancer: an interview with Brian Tomlinson

Sociologists to explore ideas, scientific research relating to sexuality at ASA's Annual Meeting

Expectant management remains underused for men with low-risk prostate cancer

Testosterone, cortisol hormones may destabilise financial markets by making traders take more risks

Men referred for borderline testosterone levels have much higher rates of depression than general population

New research links mutations in TEX11 gene to some cases of male infertility

Loyola offers holistic approach to help couples manage their sexual health

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News